Gain medically relevant insights and evidence to drive commercial and clinical business decisions, and improve patient health outcomes.

We provide consulting, research and analytics before, during and after launch,
to inform business decisions.

How we help you

  • How do you communicate the value and effectiveness of your treatment to a diverse set of stakeholders?


    Generating real-world evidence is important, to ensure your products are safe and perform as promised. With more than 30 years of experience conducting real-world patient-centric PASS and PAES studies and partnering with industry and prescribers on international patient registries, we’ll work with you to meet your evidence needs and regulatory requirements.

  • How do you get a better view of patients and markets with disparate data sources?


    You need data and analytics that are accurate and timely to address patient and product portfolio challenges. Our expertise for bringing together clinical data and patient-reported data, combined with our syndicated and custom research offers, delivers a complete and unprecedented view of patients and markets.

  • How do you commercialize medicines in complex and dynamic markets?


    Navigating brand lifecycles is complex, with little room for error. Assessing your portfolio, as well as clinical and commercial potential, understanding the market landscape, and identifying your target audience and the most effective channel for reaching them can be daunting. Kantar can help.

  • How do you optimize your asset to win a therapeutic category?


    Greater understanding, treatment development and regulatory measures are facilitating innovation in oncology and rare diseases. We bring specialized data and insights to successfully develop and commercialize your treatment.